Compare MPLX LP (MPLX) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MPLX LP vs Tempus AI — how do they compare? MPLX LP trades at $57.42 (market cap $57.84B), while Tempus AI trades at $70 (market cap $12.77B). The key difference: MPLX LP is far larger — about 4.5× Tempus AI's market cap, and MPLX LP pays a 7.55% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| MPLX | TEM | |
|---|---|---|
Market Cap | $57.84B | $12.77B |
Volume | 1,104,749 | 8,980,490 |
Sector | Energy | Broad Market / Factor |
52-Week High | $60.51 | $99.28 |
52-Week Low | $47.80 | $41.55 |
Enterprise Value | $82.94B | $13.40B |
Dividend Yield | 7.55% | — |
Typical Hold Time | — | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MPLX trades at $57.05, down 1.25% with a bearish technical signal. The company maintains strong profitability with 40.45% net income margin and 33.95% ROE, though recent earnings missed expectations in two consecutive quarters. Analyst consensus remains strongly bullish with a $63.80 price target, representing 12% upside potential. Recent news highlights MPLX's resilience in volatile energy markets through fee-based revenue models and strong distribution coverage.
The outlook remains positive given strong cash flow generation and dividend sustainability, though risks include energy market volatility and recent earnings misses. With 68% analyst buy ratings and solid fundamentals, MPLX presents a compelling income opportunity despite near-term technical weakness and sector headwinds.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MPLX LP
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
